NL7900872A - Werkwijze voor het behandelen van hyperlipoproteinemie en hyperlipidemie. - Google Patents

Werkwijze voor het behandelen van hyperlipoproteinemie en hyperlipidemie.

Info

Publication number
NL7900872A
NL7900872A NL7900872A NL7900872A NL7900872A NL 7900872 A NL7900872 A NL 7900872A NL 7900872 A NL7900872 A NL 7900872A NL 7900872 A NL7900872 A NL 7900872A NL 7900872 A NL7900872 A NL 7900872A
Authority
NL
Netherlands
Prior art keywords
hyperlipidemia
treating hyperlipoproteinemia
hyperlipoproteinemia
treating
Prior art date
Application number
NL7900872A
Other languages
English (en)
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT4790078A external-priority patent/IT1104165B/it
Priority claimed from IT4935478A external-priority patent/IT1156740B/it
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of NL7900872A publication Critical patent/NL7900872A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL7900872A 1978-02-03 1979-02-02 Werkwijze voor het behandelen van hyperlipoproteinemie en hyperlipidemie. NL7900872A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT4790078A IT1104165B (it) 1978-02-03 1978-02-03 Nuova applicazione terapeutica della carnitina della acetil-carnitina e di altri derivati acilati della carnitina
IT4935478A IT1156740B (it) 1978-05-15 1978-05-15 Applicazione terapeutica della acetil-carnitina e di altri derivati acilati della carnitina

Publications (1)

Publication Number Publication Date
NL7900872A true NL7900872A (nl) 1979-08-07

Family

ID=26329245

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7900872A NL7900872A (nl) 1978-02-03 1979-02-02 Werkwijze voor het behandelen van hyperlipoproteinemie en hyperlipidemie.

Country Status (6)

Country Link
US (1) US4268524A (nl)
JP (1) JPS54113442A (nl)
CH (1) CH640413A5 (nl)
DE (1) DE2903579A1 (nl)
GB (1) GB2013496B (nl)
NL (1) NL7900872A (nl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1156741B (it) * 1978-05-15 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi
IT1206954B (it) * 1979-02-12 1989-05-17 Sigma Tau Ind Farmaceuti Agenti terapeutici a base di un acil derivato della carnitina per la cura di vasculopatie periferiche
IT1116037B (it) * 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
IT1145362B (it) * 1980-03-06 1986-11-05 Sigma Tau Ind Farmaceuti Classe di acil-derivati della carnitina procedimento per la loro preparazione e loro uso terapeutico
IT1143214B (it) * 1981-07-09 1986-10-22 Sigma Tau Ind Farmaceuti Acil derivato della carnitina quale immunomodulatore
IT1150751B (it) * 1982-04-01 1986-12-17 Montedison Spa Composizioni acaricide
IT1157238B (it) * 1982-10-29 1987-02-11 Sigma Tau Ind Farmaceuti Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile
FR2619007B1 (fr) * 1987-08-07 1990-09-28 Dermatologiques Et Preparations cosmetiques a action lipolytique
FR2633929B2 (fr) * 1987-09-25 1995-05-24 Picardie Universite Derives non toxiques de l'acide n-butyrique, presentant des actions therapeutiques retardees
IT1224842B (it) * 1988-12-27 1990-10-24 Sigma Tau Ind Farmaceuti Uso di derivati della l-carnitina nel trattamento terapeutico delle alterazioni degenerative del sistema nervoso
IT1231944B (it) * 1989-05-05 1992-01-16 Sigma Tau Ind Farmaceuti Composizione farmaceutica per il trattamento di protozoosi, particolarmente della tripasonomiasi comprendente d-carnitina o un alcanoilderivato della d-carnitina
FR2654619B1 (fr) * 1989-11-23 1992-01-31 Sederma Sa Utilisation en cosmetique de composes destines a optimiser la penetration des principes actifs.
IT1248321B (it) * 1991-05-15 1995-01-05 Sigma Tau Ind Farmaceuti Uso di esteri di acil l-carnitine con l'acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie
US6080428A (en) * 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6129930A (en) * 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1293067B1 (it) * 1997-07-01 1999-02-11 Sigma Tau Ind Farmaceuti Composizione farmaceutica per il trattamento di patologie causate da alterato metabolismo lipidico
ITRM20010708A1 (it) * 2001-12-04 2003-06-04 Sigma Tau Ind Farmaceuti Uso di una alcanoil l-carnitina per il trattamento della disfunzione erettile.
DE10331202A1 (de) * 2003-07-10 2005-03-31 S.K. Enterprise Gmbh Verwendung von Molkenpermeat zur Behandlung des Metabolischen Syndroms
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
ITRM20040307A1 (it) 2004-06-23 2004-09-23 Sigma Tau Ind Farmaceuti Confezione per almeno due prodotti differenti da vendere e utilizzare insieme.
JP2006347935A (ja) * 2005-06-15 2006-12-28 Masanori Ogata 炎症性サイトカインの産生が関与する疾患の予防及び／又は治療のための医薬
EP2789341A3 (en) * 2005-11-11 2015-01-14 V. Ravi Chandran O-acetylated amino acids as anti-platelet agents and nutritional supplements
DE102006036285A1 (de) 2006-08-03 2008-02-07 "S.U.K." Beteiligungs Gmbh Fraktionen aus Molkepermeat und deren Verwendung zur Prävention und Therapie des Typ-2 Diabetes und des Metabolischen Syndroms
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3810994A (en) * 1972-06-01 1974-05-14 Ethyl Corp Method and composition for treating obesity
US3968241A (en) * 1972-11-06 1976-07-06 Defelice Stephen L Method of treating cardiac arrhythmias and of improving myocardial contractility and systolic rhythm with carnitive or a pharmaceutically acceptable salt thereof
US4032641A (en) * 1976-06-09 1977-06-28 Tanabe Seiyaku Co., Ltd. Nicotinoyl carnitine derivatives
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
IT1143611B (it) * 1977-11-03 1986-10-22 Sigma Tau Ind Farmaceuti Applicazione della acetil-carnitina nella terapia delle affezioni cardiache di/tipo anossico,ischemico,cardiotossico e nelle sindromi aritmiche

Also Published As

Publication number Publication date
US4268524A (en) 1981-05-19
JPS649289B2 (nl) 1989-02-16
DE2903579A1 (de) 1979-08-09
GB2013496A (en) 1979-08-15
JPS54113442A (en) 1979-09-05
GB2013496B (en) 1983-01-12
CH640413A5 (it) 1984-01-13

Similar Documents

Publication Publication Date Title
NL7900872A (nl) Werkwijze voor het behandelen van hyperlipoproteinemie en hyperlipidemie.
NL7904607A (nl) Werkwijze voor het behandelen van water.
NL7901766A (nl) Werkwijze en inrichting voor het vervaardigen van cement bevattende panelen.
NL7606685A (nl) Werkwijze voor het behandelen van afval.
BE875527A (fr) Methode en installatie voor het behandelen en verwerken van metaalslakken
NL179678C (nl) Werkwijze en stelsel voor het afvoeren van condensaat.
NL7902589A (nl) Inrichting voor het behandelen van oppervlakken.
NL7802745A (nl) Bekledingsmengsel en werkwijze voor het bekle- den van oppervlakken.
NL7900871A (nl) Werkwijze voor de therapeutische behandeling van hyperlipidemie en hyperlipiproteinemie.
NL191088C (nl) Werkwijze voor het vormen en behandelen van staalstaaf.
NL7904529A (nl) Werkwijze en inrichting voor het vervaardigen van glas- panelen.
NL181523C (nl) Werkwijze en oven voor het verbranden van afval.
NL7904393A (nl) Werkwijze voor het behandelen van oppervlakken.
NL7900766A (nl) Werkwijze voor het voorkomen en behandelen van rheumatoide arthritis.
NL7904059A (nl) Preparaat voor het reduceren van technetium, werkwijze voor de bereiding daarvan, en toepassingen daarvan.
NL7902210A (nl) Elektrolyse-elektrode, alsmede werkwijze voor het vervaardigen daarvan.
NL7900583A (nl) Werkwijze voor het behandelen van afvalslakken.
NL7807163A (nl) Werkwijze voor het behandelen van warmtegevoelige mate- rialen.
NL7901642A (nl) Materiaal voor het controleren van morsen en toepassing daarvan.
BE878224A (fr) Werkwijze voor het bepalen van glutamaatoxaalacetaattransaminase of flutamaatpyruvaattransaminase en een reagenscombinatie voor de bepaling hiervan
NL7812164A (nl) Werkwijze voor het behandelen van hypertensie en daarop betrekking hebbende geneesmiddelen.
NL7807898A (nl) Werkwijze voor het behandelen van calciumcarbonaat mineraal.
NL7902211A (nl) Werkwijze voor het hanteren van polymeer-brij.
NL7902522A (nl) Werkwijze en stelsel voor het draineren van grondwater.
NL7809139A (nl) Werkwijze voor het behandelen van vuilnis.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed